「INDUCE」に関連した英語例文の一覧と使い方(20ページ目) - Weblio英語例文検索

On a global economic level, distortions in the allocation of resources and the international division of labor have also become serious problems. Even when subsidies are used to make up for short-term market failures, the potential for their purpose and terms of use to be subverted remains. Subsidies that are used as part of a "beggar-thyneighbour" policy ultimately may induce counter subsidies, leading to "subsidy wars." Subsidy policies will then be to blame not only for preventing a product from achieving its proper competitive position, but for needlessly draining the treasuries of the countries involved. The result is a larger burden for taxpayers. In no way, therefore, do such policies improve the economic welfare of anyone concerned.例文帳に追加

更に、ある国の補助金政策が別の国の産業に損害を与え（近隣窮乏化政策）、結果的に相手国の対抗的な補助政策を誘発して補助金競争を招く場合には、当該産品に関する適正な競争条件が損なわれるだけでなく、いたずらに両国の財政状況の悪化又は納税者の負担を増大させることとなり、何ら経済厚生を高めるものとはならないと言えよう。 - 経済産業省

(viii) Induce the Policyholder or the insured to apply for an insurance contract, knowing that a specified person concerned with the Insurance Company, etc. or Foreign Insurance Company, etc. (meaning a specified person concerned as set forth in Article 100-3 (including the cases where it is applied mutatis mutandis pursuant to Article 272-13, paragraph (2); the same shall apply in Article 301) or a specified person concerned as set forth in Article 194, other than an Insurance Holding Company or Small Amount and Short Term Insurance Holding Company of which the Insurance Company, etc. or Foreign Insurance Company, etc. is a subsidiary (referred to as "Insurance Holding Company, etc." hereinafter in this Article as well as in Article 301-2), a subsidiary company of the Insurance Holding Company, etc. (other than an Insurance Company, etc. or Foreign Insurance Company, etc.), or a person carrying on Insurance Business) has promised to offer, or actually offered, a special advantage to the Policyholder or the insured. 例文帳に追加

八　保険契約者又は被保険者に対して、当該保険契約者又は被保険者に当該保険会社等又は外国保険会社等の特定関係者（第百条の三（第二百七十二条の十三第二項において準用する場合を含む。第三百一条において同じ。）に規定する特定関係者及び第百九十四条に規定する特殊関係者のうち、当該保険会社等又は外国保険会社等を子会社とする保険持株会社及び少額短期保険持株会社（以下この条及び第三百一条の二において「保険持株会社等」という。）、当該保険持株会社等の子会社（保険会社等及び外国保険会社等を除く。）並びに保険業を行う者以外の者をいう。）が特別の利益の供与を約し、又は提供していることを知りながら、当該保険契約の申込みをさせる行為 - 日本法令外国語訳データベースシステム

Hitachi has subjected itself to the corporate analysis with the use of the above-mentioned method because it has expectations that (i) since the Hitachi group is the aggregate of companies in diversified industry sectors, the individual and objective understanding of intellectual capital possessed by each business division would help reveal the strengths/weaknesses of each division and make it easier to cooperate cross-divisionally and to divide the roles between the administrative division (the head office function) and business divisions; (ii) the visualization of invisible intellectual capital, such as the morale of employees and brands, would induce each employee to become "aware" of problems the company and employees are faced with.例文帳に追加

日立が上記のような手法を活用した企業分析を受けているのは、①日立グループが多様な業種の集合体であるため、各事業部の有する知的資本を個別・客観的に明らかにすることで、各事業部の強みや弱みが明らかになり、事業部間での連携や管理部門たるコーポレート（本社機能）と各事業部との役割分担が容易になること、また、②従業員のやる気やブランド等の目に見えない知的資本をできる限り可視化することで、会社や自分たちの抱える問題点についての「気づき」を従業員１人１人に誘発することが可能になること、という効果があるのではないかと期待しているからである。 - 経済産業省

168.3. In particular, and without in any way limiting the scope of protection against unfair competition, the following shall be deemed guilty of unfair competition: (a) Any person, who is selling his goods and gives them the general appearance of goods of another manufacturer or dealer, either as to the goods themselves or in the wrapping of the packages in which they are contained, or the devices or words thereon, or in any other feature of their appearance, which would be likely to influence purchasers to believe that the goods offered are those of a manufacturer or dealer, other than the actual manufacturer or dealer, or who otherwise clothes the goods with such appearance as shall deceive the public and defraud another of his legitimate trade, or any subsequent vendor of such goods or any agent of any vendor engaged in selling such goods with a like purpose; (b) Any person who by any artifice, or device, or who employs any other means calculated to induce the false belief that such person is offering the services of another who has identified such services in the mind of the public; or (c) Any person who shall make any false statement in the course of trade or who shall commit any other act contrary to good faith of a nature calculated to discredit the goods, business or services of another.例文帳に追加

168.3特に，如何なる場合においても不正競争に対する保護の範囲を制限することなく，次に該当する者は，不正競争の罪を犯したものとみなす。 (a)自己の販売する商品の商品自体，その商品を入れる容器の包装紙又はそれらに付す図案若しくは語その他の外観上の特徴に，当該商品が実際の製造者若しくは販売者以外の者の商品であると購入者に思わせるように影響する虞がある他の製造者若しくは販売者の商品の概略の外観を与え，又はそのような目的をもって公衆を欺瞞し，かつ，他人からその者の正当な取引を詐取し，後の販売者から当該商品を詐取し，若しくは販売店から当該商品の販売に携わる販売者を詐取するような外観を自己の商品に与える者 (b)ある特定のサ－ビスを提供している他人のそのサ－ビスを自己が提供しているものと公衆に誤って信用させることを意図した術策，策略その他の手段を用いる者 (c)取引の場において虚偽の陳述をし，又は他人の商品，事業若しくはサ－ビスの信用を傷付けることを意図するような性質の善意に反するその他の行為を行う者 - 特許庁

These include substances showing positive result(s) in in vivo heritable mutagenicity tests in mammalian germ cells (rodent dominant lethal mutation test, mouse heritable translocation assay, mouse specific locus test, etc.), or positive result(s) in in vivo mutagenicity tests in mammalian somatic cells (mammalian bone marrow chromosome aberration test, mammalian erythrocyte micronucleus test, mouse spot test, etc.) in combination with some evidence that the substance has potential to induce mutations in germ cells (for example, positive results in mammalian spermatogonial chromosome aberration test, spermatid micronucleus assay, sister chromatid exchange analysis in spermatogonia, unscheduled DNA synthesis (UDS) test in testicular cells, or evidence of exposure of germ cells to the active substance or its metabolite(s)), or positive results showing mutagenicity in human germ cells without evidence of transmission to progeny (for example, an increase in the frequency of aneuploidy in sperm cells of exposed human subjects).例文帳に追加

これには、哺乳類を用いた生殖細胞のin vivo 遺伝性変異原性試験（げっ歯類優性致死突然変異試験、マウス遺伝性転座検定、マウス特定座位試験など）で陽性の場合、または、哺乳類を用いた体細胞のin vivo 変異原性試験（哺乳類骨髄細胞染色体異常試験、哺乳類赤血球小核試験、マウススポット試験など）の陽性に加えて、当該物質が生殖細胞に突然変異を誘発する可能性についての何らかの証拠（例えば、哺乳類精原細胞染色体異常試験、精子細胞小核試験、精原細胞を用いた姉妹染色分体交換分析、精巣細胞を用いた不定期DNA 合成試験（UDS）などでの陽性結果や、活性を示す当該物質あるいは代謝物質の生殖細胞への曝露の証拠など）がある場合、または、次世代への遺伝の証拠はないがヒト生殖細胞に変異原性を示す陽性結果がある場合（例えば、暴露されたヒトの精子細胞中の異数性発生頻度の増加など）が該当する。 - 経済産業省